drugset / Trial / NCT00127764

European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus

NCT00127764 ↗

Phase 2/3 Completed 60 enrolled University Medical Center Groningen
RandomizedParallel-groupDouble-blindTreatment

Summary

By this study, the investigators want to test if the value of adjuvant pulse glucocorticoid therapy for pemphigus can be determined by comparing an experimental arm (dexamethasone pulse therapy, prednisolone, and azathioprine) with a control arm (placebo pulse therapy, prednisolone, and azathioprine). The investigators will determine the rate of complete remission with dexamethasone pulse therapy; the time needed for complete remission; and the duration of remission, and compare these data with those of the placebo arm.

Timeline

Start
2001-01
Primary completion
—
Completion
2005-04

Outcome

Missed primary endpoint

paper We found no statistically significant difference (P>.05) of an adjuvant effect of DP on remission of pemphigus vulgaris. PMID 16702494 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 300 mg Oral

Indications